Health System and Patient Factors Facilitating the Implementation of Isoniazid Preventive Therapy for People living with HIV attending Care and Treatment Centres in Songea Municipality, Tanzania

Festo Komba, Frumence Gasto


Abstract Isoniazid Preventive Therapy (IPT) is an essential public health intervention for people living with HIV (PLHIV), especially in low-income countries with high tuberculosis (TB) and HIV burden. Despite available evidence that IPT is efficacious, its implementation is still low in many countries. Therefore, this study aimed to determine the coverage of IPT implementation and explore factors facilitating the implementation of IPT in Songea municipality, Tanzania. The study employed a cross-sectional descriptive study design using both quantitative and qualitative approaches of data collection. A review of 2148 records of PLHIV eligible for IPT was done to determine coverage of IPT implementation. 21 in-depth interviews and 5 observations were conducted to explore factors facilitating IPT implementation. Overall,IPT coverage of the municipality was estimated to be 45%. The study revealed that the availability of IPT training, regular supportive supervision, collaboration between TB and HIV programs, availability of IPT guidelines and patient registers were the main factors facilitating the implementation of IPT. The study recommends that local government authorities, managements of healthcare facilities, drug suppliers, and partners working in TB and HIV programs, service providers, community leaders and community health workers should continue working together and ensure that the identified facilitating factors are sustained to increase the coverage of IPT to reach at least the minimum 50% as recommended by the WHO.

Full Text:




Akolo, C., I. Adetifa, S. Shepperd & J. Volmink. (2010). Treatment of Latent Tuberculosis

Infection in HIV Infected Persons. Cochrane Database of Systematic Reviews, Issue 1. Art. No.:


Ayele, A.A., S. A. Atnafie, D..D Balcha, A.T. Weredekal, B.A. Woldegiorgis, … & M.M.

Wotte. (2017). Self-Reported Adherence and Associated Factors to Isoniazid Preventive

Therapy for Latent Tuberculosis Among People Living With HIV/AIDS At Health

Centers in Gondar Town, North West Ethiopia.Patient Prefer Adherence, 11:743–9.

Berhe. M., M. Demissie, G. Tesfaye, M. Berhe, M. Demissie & G. Tesfaye. (2014).

Isoniazid Preventive Therapy Adherence and Associated Factors Among HIV Positive

Patients in Addis Ababa, Ethiopia. Advances in Epidemioly, 2014:1–6.

Conrad, K. B., L. Mteic, D. R. Brooksd, R. Waddelle, M. Bakaric, M. Mateec, … & CRH.

(2014). Increased Mortality Associated With Treated Active Tuberculosis in HIVInfected Adults in Tanzania. NIH Public Access, 4(93):461–466.

Fusch, P. I. & Ness, L. R. (2015). Are We There Yet? Data Saturation in Qualitative Research.

(9), 1408–1416.

Ibrahim, M. (2012). Thematic Analysis : A Critical Review of Its Process and Evaluation. 1(1), 39–47.

Mesele Mindachew, Amare Deribew, Peter Memiah, S. B. (2014). Perceived Barriers to the

Implementation of Isoniazid Preventive Therapy for People Living With Hiv in Resource

Constrained Settings: A Qualitative Study. 8688, 1–6. 10.11604/ pamj.


Tanzania Commission for AIDS and Zanzibar AIDS Commission. (2018). Tanzania HIV

Impact Survey, (This) 2016-2017: Final Report. Dar es Salaam, Tanzania.

Getahun, H., R. Granich, D. Sculier, C. Gunneberg, L. Blanc, … & P. Nunn. (2010).

Implementation of Isoniazid Preventive Therapy for People Living With HIV

Worldwide : Barriers and Solutions. AIDS, 24 (Suppl. 5):S57–S65.

Golub, J., V. Saraceni, C. Solange, P. Antonio, L. Moulton, … & B. King. (2007). The

Impact of Antiretroviral Therapy and Isoniazid Preventive Therapy on Tuberculosis

Incidence in Hiv-Infected Patients in Rio De Janeiro, Brazil. AIDS,21(11):1441–8.

Habakkuk, A. Y., C. & F.N. Kuaban. (2011). Who Recommended Collaborative Tb/Hiv

Activities: Evaluation of Implementation and Performance in a Rural District Hospital

in Cameroon. Panafrican Medical Journal, 8688:4–9.

Lester, R., R. Hamilton, S. Charalambous, T. Dwadwa, C. Chandler, … & G. J.

Churchyard. (2010). Barriers to Implementation of Isoniazid Preventive Therapy in HIV

Clinics: A Qualitative Study. AIDS, 24 (Suppl. 5):S45–S48.

Makanjuola, T., H.B. Taddese & A Booth. (2014). Factors Associated with Adherence to

Treatment with Isoniazid for the Prevention of Tuberculosis Amongst People Living

with HIV/AIDS: A Systematic Review of Qualitative Data. PLoS ONE. 9(2): e87166.


Makoni, A., M. Chemhuru, M. Tshimanga, N.T. Gombe, M. Mungati & D. Bangure.

(2015). Evaluation of the Isoniazid Preventive Therapy (IPT) Program in Shurugwi

District, Midlands Province, Zimbabwe, January 2013 to August 2014. Bio Med Central

Research Notes, 8:476.


  • There are currently no refbacks.

Copyright (c) 2021 Tanzania Journal of Development Studies

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.